HT
IONS icon

HAP Trading’s Ionis Pharmaceuticals IONS Stock Holding History

HAP Trading’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,900
Closed -$128K – 2504
2021
Q4 		$128K Buy
+14,900
New +$469K ﹤0.01% 1154
2019
Q2 		– Sell
-82,000
Closed -$332K – 1236
2019
Q1 		$332K Sell
82,000
-10,200
-11% -$658K 0.03% 362
2018
Q4 		$109K Buy
+92,200
New +$4.7M 0.01% 629
2017
Q3 		– Sell
-12,100
Closed -$15K – 968
2017
Q2 		$15K Sell
12,100
-1,700
-12% -$79.2K ﹤0.01% 819
2017
Q1 		$110K Buy
+13,800
New +$620K 0.01% 556
2015
Q4 		– Sell
-38,100
Closed -$67K – 1029
2015
Q3 		$67K Buy
+38,100
New +$1.97M ﹤0.01% 669

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

HAP Trading's IONS Position: Q4 2021 in Review

HAP Trading sold out of Ionis Pharmaceuticals (IONS) in Q4 2021, closing a stake of 11,877 shares — an estimated $374K sold.

HAP Trading first reported a position in IONS in Q2 2013 and held it in 4 quarters. The position peaked at $2.14M in Q1 2019. 340 funds tracked by Wall St. Rank hold IONS as of Q4 2021.

  • HAP Trading reported no remaining Ionis Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 11,877 Ionis Pharmaceuticals shares in Q4 2021, an estimated $374K.
  • HAP Trading first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • HAP Trading's Ionis Pharmaceuticals position peaked at $2.14M in Q1 2019.
  • 340 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.